Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Journal of Veterinary Science ; : 385-390, 2016.
Artigo em Inglês | WPRIM | ID: wpr-148729

RESUMO

Canine mammary gland tumors (CMGTs), which are the most common neoplasms in sexually intact female dogs, have been suggested as a model for studying human breast cancer because of several similarities, including relative age of onset, risk factors, incidence, histological and molecular features, biological behavior, metastatic pattern, and responses to therapy. In the present study, we established a new cell line, the SNP cell line, from a CMGT. A tumor formed in each NOD.CB17-Prkdc (scid)/J mouse at the site of subcutaneous SNP cell injection. SNP cells are characterized by proliferation in a tubulopapillary pattern and are vimentin positive. Moreover, we examined miRNA expression in the cultured cells and found that the expression values of miRNA-143 and miRNA-138a showed the greatest increase and decrease, respectively, of all miRNAs observed, indicating that these miRNAs might play a significant role in the malignancy of SNP cells. Overall, the results of this study indicate that SNP cells might serve as a model for future genetic analysis and clinical treatments of human breast tumors.


Assuntos
Animais , Cães , Feminino , Humanos , Camundongos , Idade de Início , Neoplasias da Mama , Linhagem Celular , Linhagem Celular Tumoral , Células Cultivadas , Incidência , Glândulas Mamárias Humanas , MicroRNAs , Fatores de Risco , Vimentina
2.
Arq. bras. med. vet. zootec ; 64(6): 1471-1477, Dec. 2012. tab
Artigo em Português | LILACS | ID: lil-660212

RESUMO

A expressão de receptores de estrógeno (ER) e progesterona (PR) por meio da técnica de q-PCR foi avaliada em 26 cadelas portadoras de neoplasias mamárias e cinco cadelas sem afecções mamárias (grupo controle). Os resultados mostraram que os três grupos de animais estudados - com tumor maligno ou benigno e controle - expressaram receptores de estrógeno alfa, beta e progesterona. A quantificação relativa mostrou tendência para uma expressão maior de receptores no grupo controle e menor no grupo de animais com neoplasias malignas. Além disso, observou-se expressão maior de ERα em relação ao ERβ, e as neoplasias malignas de origem mista apresentaram maiores concentrações dos receptores PR, ERα e ERβ que as neoplasias de origem epitelial.


The estrogen and progesterone receptor (ER and PR) expression with the q-PCR technique was evaluated in 26 female dog carrying of mammary tumors and five female dogs without mammary disease (control group). The results showed that the three animal groups evaluated - malignant or benign tumor and control - expressed alpha and beta estrogen and progesterone receptors. The relative quantification showed a tendency for a higher expression of receptors from the control group and smaller in the malignat tumors animal group. Also, there was a major ERα expression regarding to ERβ and the malignat tumors from mixed origin presented higher concentrations of receptors PR, ERα and ERβ, when compared to tumors of epithelial origin.


Assuntos
Animais , Feminino , Cães , Receptor alfa de Estrogênio/análise , Receptor beta de Estrogênio/análise , Receptores de Estrogênio/análise , Receptores de Progesterona/análise , Carcinoma Ductal de Mama/veterinária , Expressão Gênica , Neoplasias Mamárias Animais , Mastectomia/veterinária , Reação em Cadeia da Polimerase/veterinária
3.
Journal of Veterinary Science ; : 433-436, 2012.
Artigo em Inglês | WPRIM | ID: wpr-202774

RESUMO

The purpose of this study was to elucidate the relationship between plasma free amino acid (PFAA) levels and the clinical stages of mammary gland tumors (MGT) in dogs. PFAA levels in canines with malignant mammary tumors were decreased compared to those of healthy animals. The levels of aspartate and ornithine, in the dogs with tumor metastasis were significantly decreased when compared to those of dogs that did not have metastases. Results of this study indicate that PFAA levels could be a risk factor or biomarker for canine MGT metastasis.


Assuntos
Animais , Cães , Ácido Aspártico , Glândulas Mamárias Humanas , Metástase Neoplásica , Ornitina , Plasma , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA